SG11201400354PA - Template -fixed peptidomimetics as inhibitors of fpr1 - Google Patents
Template -fixed peptidomimetics as inhibitors of fpr1Info
- Publication number
- SG11201400354PA SG11201400354PA SG11201400354PA SG11201400354PA SG11201400354PA SG 11201400354P A SG11201400354P A SG 11201400354PA SG 11201400354P A SG11201400354P A SG 11201400354PA SG 11201400354P A SG11201400354P A SG 11201400354PA SG 11201400354P A SG11201400354P A SG 11201400354PA
- Authority
- SG
- Singapore
- Prior art keywords
- fpr1
- inhibitors
- template
- fixed peptidomimetics
- peptidomimetics
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11008121 | 2011-10-07 | ||
PCT/EP2012/069412 WO2013050346A1 (en) | 2011-10-07 | 2012-10-02 | Template -fixed peptidomimetics as inhibitors of fpr1 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201400354PA true SG11201400354PA (en) | 2014-09-26 |
Family
ID=46970289
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201400354PA SG11201400354PA (en) | 2011-10-07 | 2012-10-02 | Template -fixed peptidomimetics as inhibitors of fpr1 |
Country Status (11)
Country | Link |
---|---|
US (1) | US9957297B2 (ja) |
EP (1) | EP2764010B9 (ja) |
JP (1) | JP6294227B2 (ja) |
CN (1) | CN103842373B (ja) |
AU (2) | AU2012320674A1 (ja) |
CA (1) | CA2848584C (ja) |
ES (1) | ES2576959T3 (ja) |
IL (1) | IL231756B (ja) |
MX (1) | MX349788B (ja) |
SG (1) | SG11201400354PA (ja) |
WO (1) | WO2013050346A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101641372B (zh) | 2007-02-28 | 2012-11-28 | 波利弗尔有限公司 | 模板固定的肽模拟物 |
WO2016050360A1 (en) * | 2014-09-30 | 2016-04-07 | Polyphor Ag | Beta-hairpin peptidomimetics |
CN107636007A (zh) * | 2015-03-23 | 2018-01-26 | 波利弗尔股份公司 | β‑发夹肽模拟物 |
CN109922818B (zh) * | 2016-09-06 | 2024-02-20 | 主线生物科学公司 | Cxcr4拮抗剂及使用方法 |
CN111909238B (zh) * | 2017-06-29 | 2022-04-08 | 安徽省农业科学院农产品加工研究所 | 一种含有Ser-Cys的高锌螯合活性锌螯合肽及其应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002247724B2 (en) | 2001-02-23 | 2008-02-07 | Polyphor Ltd. | Template-fixed peptidomimetics with antimicrobial activity |
BRPI0215855B1 (pt) * | 2002-08-20 | 2016-12-13 | Polyphor Ltd | peptídeos cíclicos ligados à matriz com ação antimicrobiana |
AU2003232253A1 (en) | 2003-05-02 | 2004-11-23 | Polyphor Ag | Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity |
KR100831633B1 (ko) * | 2004-02-04 | 2008-05-22 | 포항공과대학교 산학협력단 | Fpr 계열 수용체 매개 신호전달에 대하여 길항작용 하는펩티드 |
ATE520705T1 (de) | 2005-05-02 | 2011-09-15 | Polyphor Ltd | Farbstoffkonjugate von schablonenfixierten peptidomimetika |
CN101641372B (zh) * | 2007-02-28 | 2012-11-28 | 波利弗尔有限公司 | 模板固定的肽模拟物 |
WO2010060479A1 (en) | 2008-11-26 | 2010-06-03 | Polyphor Ag | Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity |
WO2010127704A1 (en) | 2009-05-07 | 2010-11-11 | Polyphor Ag | Beta-hairpin peptidomimetics having cxcr4 antagonizing activity |
EP2438047B1 (en) * | 2009-06-02 | 2014-07-30 | Nikan Pharmaceuticals, LLC | Antagonism of human formyl peptide receptor for treatment of disease |
WO2011066869A1 (en) | 2009-12-04 | 2011-06-09 | Polyphor Ag | Beta-hairpin peptidomimetics |
-
2012
- 2012-10-02 WO PCT/EP2012/069412 patent/WO2013050346A1/en active Application Filing
- 2012-10-02 ES ES12768803.4T patent/ES2576959T3/es active Active
- 2012-10-02 SG SG11201400354PA patent/SG11201400354PA/en unknown
- 2012-10-02 AU AU2012320674A patent/AU2012320674A1/en not_active Abandoned
- 2012-10-02 CN CN201280048985.4A patent/CN103842373B/zh active Active
- 2012-10-02 JP JP2014533851A patent/JP6294227B2/ja active Active
- 2012-10-02 CA CA2848584A patent/CA2848584C/en active Active
- 2012-10-02 US US14/349,683 patent/US9957297B2/en active Active
- 2012-10-02 MX MX2014003960A patent/MX349788B/es active IP Right Grant
- 2012-10-02 EP EP12768803.4A patent/EP2764010B9/en active Active
-
2014
- 2014-03-27 IL IL231756A patent/IL231756B/en active IP Right Grant
-
2017
- 2017-06-19 AU AU2017204122A patent/AU2017204122B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US9957297B2 (en) | 2018-05-01 |
MX349788B (es) | 2017-08-11 |
NZ621974A (en) | 2015-06-26 |
EP2764010B1 (en) | 2016-03-16 |
WO2013050346A1 (en) | 2013-04-11 |
EP2764010A1 (en) | 2014-08-13 |
ES2576959T3 (es) | 2016-07-12 |
CN103842373A (zh) | 2014-06-04 |
AU2017204122B2 (en) | 2019-05-02 |
IL231756A0 (en) | 2014-05-28 |
JP6294227B2 (ja) | 2018-03-14 |
CN103842373B (zh) | 2018-12-21 |
CA2848584A1 (en) | 2013-04-11 |
AU2012320674A1 (en) | 2014-03-20 |
EP2764010B9 (en) | 2017-01-18 |
IL231756B (en) | 2019-06-30 |
ES2576959T9 (es) | 2017-05-29 |
CA2848584C (en) | 2020-03-24 |
JP2014528958A (ja) | 2014-10-30 |
MX2014003960A (es) | 2014-05-14 |
AU2017204122A1 (en) | 2017-07-06 |
US20140287986A1 (en) | 2014-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1257823A1 (zh) | 金屬酶抑制劑化合物 | |
HK1198163A1 (en) | Metalloenzyme inhibitor compounds | |
HK1198651A1 (en) | Metalloenzyme inhibitor compounds | |
HK1243175A1 (zh) | 標記的hsp90抑製劑的用途 | |
ZA201309561B (en) | Novel inhibitor compounds of phosphodiestarase type 10a | |
ZA201306221B (en) | Compounds and compositions as trk inhibitors | |
EP2723730A4 (en) | METALLOENZYMHEMMERVERBINDUNGEN | |
EP2678018A4 (en) | COMBINATION OF CHINESE HEMMER AND USES THEREOF | |
EP2706852A4 (en) | BIPYRIDYLAMINOPYRIDINES AS SYK INHIBITORS | |
EP2665724A4 (en) | BICYCLIC INHIBITORS OF ALK | |
EP2874606A4 (en) | LIPOSOMAL COMPOSITIONS OF PROTEASOMBARS ON EPOXYKETONE BASE | |
ZA201206456B (en) | Uses of dgati inhibitors | |
SMT201600001B (it) | Imidazopiridazine come inibitori di akt chinasi | |
ZA201300004B (en) | Cyrstalline form of benzylbenzene sglt2 inhibitor | |
HK1190143A1 (zh) | 作為 抑制劑的新型取代的吡啶並吡嗪類化合物 | |
HK1199252A1 (en) | Inhibitors of nedd8-activating enzyme nedd8- | |
ME02167B (me) | Piridinil- i pirazinil-metiloksi-aril derivati korisni kao inhibitori tirozin kinaze slezine (syk) | |
IL231756A0 (en) | Peptides with a fixed pattern as 1fpr inhibitors | |
EP2751117A4 (en) | METALLOENZYMHEMMERVERBINDUNGEN | |
EP2663322A4 (en) | NEW USES OF CYCLOPHILIN INHIBITORS | |
LU91725B1 (en) | Novel uses of V-ATPASE inhibitors | |
GB201104399D0 (en) | Novel inhibitors |